- Home
- BCRX vs PARR Comparison
BCRX vs PARR Comparison
Compare BCRX & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- PARR
- Stock Information
- Founded
- BCRX 1986
- PARR 1984
- Country
- BCRX United States
- PARR United States
- Employees
- BCRX N/A
- PARR N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- PARR Integrated oil Companies
- Sector
- BCRX Health Care
- PARR Energy
- Exchange
- BCRX Nasdaq
- PARR Nasdaq
- Market Cap
- BCRX 1.8B
- PARR 1.5B
- IPO Year
- BCRX 1994
- PARR N/A
- Fundamental
- Price
- BCRX $7.96
- PARR $35.62
- Analyst Decision
- BCRX Strong Buy
- PARR Hold
- Analyst Count
- BCRX 10
- PARR 6
- Target Price
- BCRX $16.70
- PARR $26.79
- AVG Volume (30 Days)
- BCRX 2.3M
- PARR 1.7M
- Earning Date
- BCRX 11-03-2025
- PARR 11-03-2025
- Dividend Yield
- BCRX N/A
- PARR N/A
- EPS Growth
- BCRX N/A
- PARR N/A
- EPS
- BCRX N/A
- PARR N/A
- Revenue
- BCRX $557,506,000.00
- PARR $7,614,628,000.00
- Revenue This Year
- BCRX $41.34
- PARR N/A
- Revenue Next Year
- BCRX $6.11
- PARR N/A
- P/E Ratio
- BCRX N/A
- PARR N/A
- Revenue Growth
- BCRX 45.85
- PARR N/A
- 52 Week Low
- BCRX $6.02
- PARR $11.86
- 52 Week High
- BCRX $11.31
- PARR $36.39
- Technical
- Relative Strength Index (RSI)
- BCRX 42.41
- PARR 60.28
- Support Level
- BCRX $7.64
- PARR $32.24
- Resistance Level
- BCRX $7.99
- PARR $36.08
- Average True Range (ATR)
- BCRX 0.22
- PARR 1.68
- MACD
- BCRX -0.03
- PARR 0.03
- Stochastic Oscillator
- BCRX 37.65
- PARR 81.45
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.